Jonathan Wadsley

11.8k citations
89 papers · 2.3k indexed · 2 hit papers · h-index 20

Jonathan Wadsley

83 papers receiving 2.2k citations

Hit Papers

Epirubicin, oxaliplatin, and capecitabine with or without...5472013202620172021100200300400500

Peers

Jonathan Wadsley
Comparison fields: 5 of 88
  • Gastroenterology 320
  • Oncology 1.2k
  • Pulmonary and Respiratory Medicine 1.3k
  • Surgery 992
  • Endocrinology, Diabetes and Metabolism 257
Replace Daisuke Takahari with:
Daisuke Takahari Japan
J R Farndon United Kingdom
Inkeun Park South Korea
Cristian Lolli Italy
C.J.H. van de Velde Netherlands
Jae Moon Bae South Korea
Tae Sung Sohn South Korea
Margherita Nannini Italy
Thomas A. Abrams United States
B Paillot France
Jonathan Wadsley relative to Daisuke Takahari Japan Daisuke Takahari's profile →
Citations per field
00.5×4.7×
Daisuke Takahari · 1×
Citations per year

Countries citing papers authored by Jonathan Wadsley

Since Specialization
Citations

This map shows the geographic impact of Jonathan Wadsley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Wadsley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Wadsley more than expected).

Fields of papers citing papers by Jonathan Wadsley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Wadsley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Wadsley. The network helps show where Jonathan Wadsley may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jonathan Wadsley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jonathan Wadsley Line = papers co-authored together Jonathan Wadsley links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20243
2 20240
3 20235
4 20232
5 20233
6 20231
7 20231
8 20223
9 20228
10 20225
11 20206
12 201920
13 201879
14 20173
15 20161
16 20146
17 201414
18 201319
19
Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trialbreakdown →
2013547
20 201224

About Jonathan Wadsley

Jonathan Wadsley is a scholar working on Oncology, Endocrinology, Diabetes and Metabolism and Cancer Research, having authored 89 papers that have together received 2.3k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (24 papers), Thyroid Cancer Diagnosis and Treatment (21 papers), Cancer Genomics and Diagnostics (16 papers), Colorectal Cancer Treatments and Studies (16 papers), Gastric Cancer Management and Outcomes (15 papers), Esophageal Cancer Research and Treatment (11 papers), Neuroendocrine Tumor Research Advances (9 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers). The work is most often cited by research in Gastroenterology (320 citations), Oncology (1.2k citations) and Pulmonary and Respiratory Medicine (1.3k citations). Jonathan Wadsley has collaborated with scholars based in United Kingdom, Germany and United States. Frequent co-authors include David Cunningham, Stephen Falk, Gary Middleton, Ian Chau, Fareeda Y. Coxon, Wasat Mansoor, Justin S. Waters, John Bridgewater, Tom Crosby and Sarah Slater. Their work appears in journals such as Journal of Clinical Oncology, Clinical Oncology, Annals of Oncology, The Lancet Oncology and BMJ Open.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026